Infectious Disease · PANCE / PANRE

Coccidioidomycosis (Valley Fever)

Endemic mycosis of the southwestern United States caused by Coccidioides immitis/posadasii; presents as community-acquired pneumonia with eosinophilia.

Also known as: valley fever, San Joaquin fever, Coccidioides immitis, Coccidioides posadasii, desert rheumatism

Overview

Infection caused by inhalation of arthroconidia from the dimorphic fungi Coccidioides immitis (San Joaquin Valley, California) and Coccidioides posadasii (Arizona, New Mexico, west Texas, Mexico, Central and South America). Manifestations range from asymptomatic infection to acute pneumonia, chronic pulmonary disease, and extrapulmonary dissemination.

Epidemiology

Endemic to the southwestern US (Arizona, central California, parts of Nevada, Utah, New Mexico, Texas), northern Mexico, and parts of Central and South America. Incidence has been rising; cases also reported in eastern Washington. Outbreaks linked to dust storms, archaeological digs, and construction.

Try two board-style Coccidioidomycosis questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1Infectious DiseaseMedium
A 45-year-old previously healthy man who lives in Tucson, Arizona, has had fever, dry cough, pleuritic chest pain, and marked fatigue for 3 weeks. Ten days ago an urgent care clinician diagnosed community-acquired pneumonia and prescribed amoxicillin 1 g three times daily for 7 days, which he completed without improvement. A complete blood count at that visit showed 10% eosinophils; today the white blood cell count is 8,600/uL with 14% eosinophils. A plain film of the chest shows a segmental consolidation in the right middle lobe. Which of the following is the most likely diagnosis?
  • APulmonary blastomycosis
  • BCoccidioidal pneumonia
  • CMycoplasma pneumonia
  • DPneumococcal pneumonia
  • EPrimary tuberculosis
Reveal answer & full explanation
Correct answer: B — Coccidioidal pneumonia
  • APulmonary blastomycosis
  • BCoccidioidal pneumonia✓
  • CMycoplasma pneumonia
  • DPneumococcal pneumonia
  • EPrimary tuberculosis

Why Coccidioidal pneumonia is correct

  • Coccidioides immitis and C. posadasii live in the soil of the desert Southwest (Arizona, especially the Phoenix and Tucson areas, and California's San Joaquin Valley); residents can be infected simply by breathing airborne spores, so a specific high-risk activity such as digging is not needed, and symptoms begin about 1-3 weeks after arthroconidia are inhaled
  • Primary coccidioidal pneumonia (Valley fever) is a subacute illness with fever, cough, pleuritic chest pain, and marked fatigue that often lasts weeks; the film usually shows a unilateral segmental or lobar consolidation, most often perihilar or basilar but possible in any lobe (the right middle lobe here), and it looks like any bacterial community-acquired pneumonia, so it is commonly treated as one first
  • Two findings point to it here: no improvement after a full, guideline-appropriate antibacterial course, and peripheral eosinophilia that was already present before the amoxicillin was started (more than 5% should raise suspicion for coccidioidomycosis), which the other choices do not typically cause
  • In endemic areas it is a common cause of outpatient pneumonia: coccidioidal infection accounted for 24% of newly diagnosed community-acquired pneumonia in ambulatory patients in two small Arizona studies cited by IDSA 2016

Why the others are wrong

  • Mycoplasma pneumonia - the strongest bacterial rival: it causes a gradual, subacute illness with a nagging dry cough and a usually normal white count, and amoxicillin does not treat it because Mycoplasma has no cell wall; but it does not explain peripheral eosinophilia, and in a Tucson resident whose pneumonia has failed antibacterial therapy, coccidioidomycosis is the more likely cause (the trap is assuming that failure of a beta-lactam must mean an atypical bacterium)
  • Pneumococcal pneumonia - the most common bacterial cause of a lobar infiltrate, but it typically begins abruptly with rigors and productive sputum and usually raises the neutrophil count, and amoxicillin 1 g three times daily (an ATS/IDSA 2019 first-line outpatient regimen for healthy adults) is active against most strains; a 3-week illness with a normal white count and eosinophilia that did not improve after a full course does not fit (the trap is premature closure on the most common cause of cough plus infiltrate)
  • Primary tuberculosis - TB belongs on the differential of a pneumonia that does not resolve on standard antibiotics, and primary TB can produce a middle- or lower-lobe infiltrate like this one, but nothing here suggests a TB exposure and peripheral eosinophilia is not a feature of tuberculosis; reactivation TB, the usual adult form, favors the upper lobes with cavitation (the trap is jumping to TB for every nonresolving pneumonia without weighing local epidemiology)
  • Pulmonary blastomycosis - like coccidioidomycosis, acute pulmonary blastomycosis can produce a segmental or lobar consolidation that mimics bacterial community-acquired pneumonia and does not respond to antibacterial therapy, but Blastomyces is endemic around the Great Lakes and the Ohio and Mississippi River basins rather than the desert Southwest, and it does not typically cause peripheral eosinophilia (the trap is recognizing an endemic mycosis without matching the fungus to its geography)

Additional high-yield points

  • Consider coccidioidomycosis in every patient with community-acquired pneumonia who lives in or has recently traveled to an endemic area, not only after antibiotics fail; repeated empiric antibacterial courses delay the diagnosis
  • Confirm with serology: enzyme immunoassay for IgM and IgG, confirmed by immunodiffusion, with complement fixation titers to track disease burden (a titer above 1:16 suggests more extensive disease or dissemination); early serology can be negative, so repeat it in 2-4 weeks when suspicion persists
  • Erythema nodosum and arthralgias (desert rheumatism) support the diagnosis when present and signal a lower risk of dissemination, but many patients with coccidioidal pneumonia have neither, so their absence does not argue against it
  • Most immunocompetent patients with uncomplicated primary infection recover with observation and follow-up; fluconazole is used for debilitating or prolonged illness (symptoms > 2 months, weight loss > 10%, extensive infiltrates) or a high risk of severe or disseminated disease (immunosuppression, diabetes, third-trimester pregnancy, African or Filipino ancestry); amphotericin B is used for severe or rapidly progressive disease and in first-trimester pregnancy, when azoles are avoided as teratogens
  • Dissemination (skin, bones and joints, meninges) is uncommon; coccidioidal meningitis requires lifelong azole therapy
  • Geography of the endemic mycoses: Coccidioides in the desert Southwest; Histoplasma in the Ohio and Mississippi River valleys (bird or bat droppings); Blastomyces around the Great Lakes and the Ohio and Mississippi River basins (wooded riverbanks), classically with verrucous skin lesions
Question 2Infectious DiseaseEasy
A 34-year-old previously healthy man presents with three weeks of fever, dry cough, fatigue, and pleuritic chest pain. He recently returned from a two-month construction project in Bakersfield, California. On exam, he has tender erythematous nodules on his shins. Chest radiograph shows a left upper lobe infiltrate with ipsilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis?
  • ABlastomycosis
  • BCoccidioidomycosis
  • CSarcoidosis
  • DTuberculosis
  • EHistoplasmosis
Reveal answer & full explanation
Correct answer: B — Coccidioidomycosis
  • ABlastomycosis
  • BCoccidioidomycosis✓
  • CSarcoidosis
  • DTuberculosis
  • EHistoplasmosis

Why Coccidioidomycosis is correct

  • A subacute pneumonia with erythema nodosum (desert rheumatism or Valley fever) in a patient with recent exposure to San Joaquin Valley soil is classic for coccidioidomycosis.
  • Coccidioides immitis and C. posadasii are endemic to the arid southwestern United States, including Bakersfield.
  • Inhalation of arthroconidia from disturbed soil produces a flu-like illness with hilar adenopathy and a striking association with erythema nodosum and arthralgias.

Why the others are wrong

  • Tuberculosis — can produce upper-lobe disease with hilar adenopathy but typically involves weeks-to-months of night sweats and weight loss with an epidemiologic risk factor, not the erythema nodosum-plus-Valley-exposure syndrome (anchoring).
  • Blastomycosis — occurs in the south-central and Great Lakes regions and characteristically causes verrucous skin lesions and lytic bone disease rather than erythema nodosum (confused-with endemic mycosis).
  • Histoplasmosis — endemic to the Ohio and Mississippi River valleys and linked to bird/bat guano, not desert construction (confused-with endemic mycosis).
  • Sarcoidosis — erythema nodosum with hilar adenopathy and fever suggests Löfgren syndrome, but Löfgren adenopathy is bilateral and symmetric, whereas a unilateral upper-lobe infiltrate with ipsilateral hilar nodes after San Joaquin Valley soil exposure points to Valley fever; sarcoidosis remains a diagnosis of exclusion after granulomatous infection is ruled out (confused-with Löfgren syndrome).

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Coccidioidomycosis (Valley Fever) outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Residence in or travel to endemic areas
  • Occupational dust exposure: construction, archaeology, agriculture, military training
  • Pregnancy (third trimester and postpartum, especially for dissemination)
  • African American or Filipino ethnicity (higher risk of dissemination)
  • HIV/AIDS with CD4 <250 cells/microL
  • Solid organ transplantation, TNF-alpha inhibitor therapy
  • Diabetes mellitus (associated with chronic pulmonary disease)

Pathophysiology

Arthroconidia released from soil are inhaled and convert to large spherules containing endospores within tissue. Endospores rupture, releasing new endospores that propagate locally and may disseminate via lymphohematogenous spread. Cell-mediated immunity is critical for control. Defective Th1 response permits dissemination to skin, bones, joints, and central nervous system.

Clinical presentation

Symptoms

  • 60% of infections are asymptomatic
  • Acute pulmonary: fever, fatigue, dry cough, pleuritic chest pain, headache, arthralgias 1-3 weeks after exposure
  • Erythema nodosum or erythema multiforme (more common in women)
  • Severe fatigue lasting weeks to months
  • Chronic pulmonary: persistent cough, hemoptysis, weight loss, cavitary or nodular lesions
  • Disseminated: skin nodules/ulcers, lytic bone lesions, monoarticular arthritis, chronic meningitis with headache and confusion

Signs / physical exam

  • Lower lobe crackles or consolidation
  • Erythema nodosum on shins ('desert bumps')
  • Cutaneous papules, plaques, or verrucous lesions in disseminated disease
  • Joint effusion in monoarticular arthritis
  • Meningeal signs, cranial nerve palsies in CNS disease

Classic findings

Triad of fever, erythema nodosum, and arthralgias ('desert rheumatism') in a patient with recent travel to Arizona or central California. Peripheral eosinophilia is highly suggestive.

Differential diagnosis

  • Community-acquired bacterial pneumonia — Acute onset, lobar consolidation, leukocytosis without eosinophilia; geography and exposure should prompt fungal serology in endemic areas
  • Tuberculosis — Chronic cough, weight sweats, upper-lobe cavitation; AFB testing and Coccidioides serology may both be required
  • Histoplasmosis — Different geography (Ohio/Mississippi valleys), bird/bat exposure, intracellular yeast on histopathology
  • Sarcoidosis — Bilateral hilar adenopathy, non-caseating granulomas, elevated ACE; coccidioidomycosis can mimic on imaging
  • Lung malignancy — Solitary pulmonary nodule; coccidioidomas mimic; biopsy or growth on imaging required to distinguish
  • Eosinophilic pneumonia — Peripheral eosinophilia, infiltrates; rule out parasitic and drug causes; Coccidioides serology in endemic regions
  • Erythema nodosum from sarcoid, IBD, or strep — Coccidioidomycosis is a classic infectious cause; serology in endemic exposure

Diagnostic workup

Diagnostic criteria

Definitive: positive culture or histopathologic identification of characteristic spherules (10-80 microm) containing endospores. Presumptive: positive Coccidioides serology with compatible clinical picture in endemic-exposure patient.

Labs

  • Coccidioides serology: EIA for IgM and IgG (initial screen), confirmed by immunodiffusion and complement fixation
  • Complement fixation titer correlates with disease severity; titer >1:16 (1:32 or higher) suggests dissemination
  • CBC with differential (eosinophilia in 25-30%)
  • ESR, CRP
  • Fungal culture of sputum, BAL, or tissue (handle in biosafety level 3 facility — highly infectious)
  • CSF analysis with cell count, glucose, protein, Coccidioides CF antibody if meningitis suspected

Imaging

  • Chest x-ray: patchy infiltrates, hilar adenopathy, nodules, or thin-walled cavities
  • Chest CT for nodule and cavity characterization
  • MRI brain with contrast for suspected CNS disease (basilar meningeal enhancement, hydrocephalus)
  • Bone scan or MRI for suspected osteomyelitis

Diagnostic algorithm

flowchart TD
  A[Inhaled arthroconidia<br/>SW US, dust exposure] --> B[Spherules in tissue]
  B --> C{Host response}
  C -->|Most| D[Asymptomatic /<br/>mild flu-like illness]
  C -->|Symptomatic 40%| E[Acute pulmonary<br/>fever, EN, arthralgias, eosinophilia]
  C -->|Immunocompromised,<br/>Filipino/AA, pregnancy| F[Dissemination]
  F --> G[Skin / bone /<br/>joint]
  F --> H[Meningitis<br/>basilar enhancement]
  E --> I[Observe or fluconazole<br/>3-6 mo]
  G --> J[Fluconazole >=12 mo]
  H --> K[Fluconazole 800-1200 mg<br/>LIFELONG]
Coccidioidomycosis clinical spectrum and treatment intensity by host and disease form.

Treatment

First-line

  • Uncomplicated primary pulmonary in immunocompetent: observation with close follow-up is appropriate for many patients; treat if symptoms severe, prolonged >2 months, or CF titer >1:16
  • Treatment of acute pulmonary disease requiring therapy: azole antifungal — fluconazole 400 mg PO daily or itraconazole 200 mg PO BID for 3-6 months
  • Diffuse pulmonary disease, dissemination, or immunocompromised: fluconazole 400-800 mg PO daily for at least 12 months; severe cases start with liposomal amphotericin B 3-5 mg/kg/day
  • Meningitis: fluconazole 800-1200 mg PO daily LIFELONG (relapse rate near 80% if discontinued)
  • Pregnancy: first trimester, IV amphotericin B (lipid formulation) because azoles are teratogenic; after the first trimester, fluconazole or itraconazole can be considered

Second-line / adjunct

  • Voriconazole or posaconazole for azole-refractory or intolerant patients
  • Intrathecal amphotericin B for fluconazole-refractory meningitis (specialty centers)
  • Surgical debridement for refractory bone or soft tissue disease, or large cavities with hemoptysis
  • Ventriculoperitoneal shunt for hydrocephalus complicating meningitis

Complications

  • Progressive pulmonary disease with cavitation, hemoptysis, or pyopneumothorax from cavity rupture
  • Disseminated infection to skin, bones, joints, soft tissue
  • Coccidioidal meningitis with hydrocephalus, stroke, and high mortality if untreated
  • Reactivation in immunocompromised hosts
  • Drug toxicity from prolonged azole therapy (hepatotoxicity, QT prolongation, alopecia)

PANCE pearls

  • Peripheral eosinophilia in a patient with pneumonia and recent southwestern US travel is coccidioidomycosis until proven otherwise.
  • Filipino and African American patients have a markedly higher risk of dissemination and CNS disease.
  • Pregnancy in the third trimester is one of the strongest risk factors for dissemination.
  • Coccidioidal meningitis requires LIFELONG fluconazole — relapse rate is approximately 80% if therapy is stopped.
  • Solitary pulmonary nodules (coccidioidomas) often do not require treatment but must be distinguished from malignancy.

References

  • IDSA 2016 — 2016 Infectious Diseases Society of America Clinical Practice Guideline for the Treatment of Coccidioidomycosis (Galgiani et al., Clin Infect Dis 2016)
  • CDC — CDC — Valley Fever (Coccidioidomycosis): epidemiology, surveillance, clinical features

Practice Infectious Disease questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.